Combined phospho-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium

This publication has 25 references indexed in Scilit:

• Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review
  Published by Elsevier ,2014
• Involution of PTEN-null endometrial glands with progestin therapy
  Gynecologic Oncology, 2004
• Regulation of PTEN (Phosphatase and Tensin Homolog Deleted on Chromosome 10) Expression by Estradiol and Progesterone in Human Endometrium
  Journal of Clinical Endocrinology & Metabolism, 2003
• Biphasic Estradiol-induced AKT Phosphorylation Is Modulated by PTEN via MAP Kinase in HepG2 Cells
  Molecular Biology of the Cell, 2003
• Protean PTEN: Form and Function
  American Journal of Human Genetics, 2002
• Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome
  Cancer Letters, 2001
• The Multiple Roles of PTEN in Tumor Suppression
  Published by Elsevier ,2000
• PTEN1 is frequently mutated in primary endometrial carcinomas
  Nature Genetics, 1997
• Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.
  Proceedings of the National Academy of Sciences, 1996
• AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.
  Proceedings of the National Academy of Sciences, 1992